領益智造(002600.SZ):子公司擬斥3100萬元參投嘉興朝希和厚股權投資合夥企業
格隆匯3月15日丨領益智造(002600.SZ)公佈,近日,廣東領益智造股份有限公司全資子公司深圳市東方亮彩精密技術有限公司(簡稱“東方亮彩”)與上海朝希私募基金管理有限公司、海南朝希諮詢管理有限公司、海南富森美投資有限責任公司等簽署了《嘉興朝希和厚股權投資合夥企業(有限合夥)合夥協議》並共同投資嘉興朝希和厚股權投資合夥企業(有限合夥)。
根據上述各方簽署的《合夥協議》,合夥企業各合夥人的合計認繳出資額為人民幣7301萬元,其中東方亮彩作為有限合夥人認繳出資人民幣3100萬元,出資比例為42.4599%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.